FindTrial
Sign In

To evaluate the efficacy of indrayanadi churna with guda in the management of Bahupitta Kamala

Randomized controlled clinical trial to evaluate the efficacy of indrayanadi churna with guda in the management of Bahupitta Kamala

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027181
Enrollment
60
Registered
2020-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B199- Unspecified viral hepatitis without hepatic coma

Interventions

Intervention1: Indrayanadi churna: Indrayanadi churna containing indrayan and shunti with anupan Guda will be administered orally, Dose 1 gm after meal of morning and night ,Duration pf therapy 28 day

Sponsors

Dr sumant Andhale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sign and symptoms of Bahupitta kamala Serum bilirubin above 3 mg/dl

Exclusion criteria

Exclusion criteria: Known cases of Ruddhapatha kamala, kumbhakamala, Halimaka ï?· Serum Bilirubin more than 12mg /dl

Design outcomes

Primary

MeasureTime frame
Indrayanadi churna with Guda is effective in the management of Bahupitta kamalaTimepoint: Indrayanadi churna with Guda is effective in the management of Bahupitta kamala in 4 week—

Secondary

MeasureTime frame
Nishottar churna with Triphala kwatha does not have or has less effective in the management of bahupitta kamala in 4 weekTimepoint: Nishottar churna with Triphala kwatha has no or less singnificant improvement in sign and symptoms of bahupitta kamala Outcome will be assessed daily from 0 day to day 28—

Countries

India

Contacts

Public ContactDr swati Soman

SST Ayurved Mahavidyalaya Sangamner

Swati.soman68@gmail.com9421438173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026